Ultime notizie per Vantage Towers (OTC:VTAGY) Azioni

Vantage is the tower arm of Vodafone, spun off in 2021. Vantage fully owns 45,000 towers in Germany, Spain, Greece, and other European countries. Vantage also owns stakes in Inwit (22,000 towers, Vantage owns 33% stake), the Italian tower operator resulting from the merger of Vodafone and Telecom Italia's towers in the region, and Cornerstone (14,000 towers, 50% stake) a tower joint venture in the U.K. with Telefonica.

VANTAGE TOWERS AG U/ADR by VANTAGE TOWERS AG

Vantage Towers AG

WIIM

VERO

Venus Concept shares are trading higher after the company announced it has been granted European Patent Number EP3542745.

Keybanc analyst Jeffrey Hammond maintains ITT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITT#NYSE">ITT</a>) with a Overweight and lowers the price target from $170 to $150.

News

Price Target

Analyst Ratings

Keybanc Maintains Overweight on ITT, Lowers Price Target to $150

Companies to construct world's largest low-carbon ammonia plant in Louisiana
Start-up of low-carbon ammonia production expected to begin in 2029
Expect to qualify for 45Q tax credit on sequestration of approximately 2.3 million metric tons of CO2 per year
CF Industries Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>), the world's largest producer of ammonia, announced today that it has formed a joint venture with JERA Co., Inc. (JERA), Japan's largest energy company, and Mitsui &amp; Co., Inc. (Mitsui), a leading global investment and trading company, for the construction, production and offtake of low-carbon ammonia.
Highlights
<ul>
<li>Joint Venture Structure: Upon formation, CF Industries will hold 40% ownership, JERA 35% ownership, and Mitsui 25% ownership in the joint venture.(1)</li>
<li>Low-Carbon Ammonia Production Facility Construction: The joint venture will construct at CF Industries' Blue Point Complex in Louisiana an autothermal reforming (ATR) ammonia production facility with a carbon dioxide (CO2) dehydration and compression unit at the site to prepare captured CO2 for transportation and sequestration. The estimated cost for the ammonia production facility is approximately $4 billion, which will be funded by each partner according to their ownership percentage.</li>
<li>Low-Carbon Ammonia Production Capacity: The low-carbon ammonia production facility will have an annual nameplate capacity of approximately 1.4 million metric tons, which would be the largest ammonia production facility by nameplate capacity in the world. Production of low-carbon ammonia is expected to begin in 2029.</li>
<li>Scalable Infrastructure: CF Industries will build and operate scalable infrastructure at the Blue Point site to supply the ammonia production facility with services, including product storage and loading. CF Industries will invest approximately $550 million for these facilities and receive ongoing services revenue from the joint venture ammonia production facility.</li>
<li>Operations: CF Industries will be responsible for the operation and maintenance of the ammonia production facility.</li>
<li>Ammonia Offtake: Product offtake will be handled independently by the three companies according to their ownership percentage.
<ul>
<li>Sequestration of Carbon Dioxide (CO2): 1PointFive, a carbon capture, utilization, and sequestration (CCUS) company and subsidiary of Occidental (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>), will transport and sequester approximately 2.3 million metric tons of CO2 annually at 1PointFive's Pelican Sequestration Hub in Louisiana.</li>
</ul>
</li>
</ul>

Contracts

CF Industries, JERA, And Mitsui Partner To Build Low-Carbon Ammonia Plant In Louisiana With $4B Investment, Set To Start Production In 2029 And Sequester 2.3M Metric Tons of CO2 Annually

JP Morgan analyst Richard Shane maintains Navient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAVI#NASDAQ">NAVI</a>) with a Neutral and lowers the price target from $13.5 to $11.

NAVI

JP Morgan Maintains Neutral on Navient, Lowers Price Target to $11

JP Morgan analyst Richard Shane maintains Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) with a Overweight and lowers the price target from $43 to $36.

ALLY

JP Morgan Maintains Overweight on Ally Financial, Lowers Price Target to $36

Susquehanna analyst James Friedman maintains Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Positive and lowers the price target from $255 to $225.

GLOB

Susquehanna Maintains Positive on Globant, Lowers Price Target to $225

Keybanc analyst Jeffrey Hammond maintains Gates Industrial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTES#NYSE">GTES</a>) with a Overweight and lowers the price target from $27 to $21.

GTES

Keybanc Maintains Overweight on Gates Industrial Corp, Lowers Price Target to $21

On Monday, the U.S. Centers for Medicare &amp; Medicaid Services (CMS) released its 2026 payment update for Medicare Advantage (MA) and Medicare Part D <a target="_blank" href="https://www.benzinga.com/topic/weight-loss" rel="noreferrer noopener">prescription drug plans</a>.
This update, along with a final rule issued on <a target="_blank" href="https://www.cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription-final" rel="noreferrer noopener">April 4</a>, Friday, includes routine annual changes and technical adjustments to both programs.
Under Friday&#8217;s <a target="_blank" href="https://public-inspection.federalregister.gov/2025-06008.pdf" rel="noreferrer noopener">ruling</a>, President Donald Trump&nbsp;scrapped the Biden administration&#8217;s move for Medicare coverage for anti-obesity treatments, negating the potential coverage for blockbuster GLP-1 drugs like Novo Nordisk A/S&#8217; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) Wegovy (semaglutide) and Eli Lilly And Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) Zepbound (tirzepatide).
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42896803/medicare-to-cover-eli-lillys-weight-loss-drug-zepbound-for-obstructive-sleep-apnea-treatment" rel="noreferrer noopener">Medicare To Cover Eli Lilly&#8217;s Weight Loss Drug Zepbound For Obstructive Sleep Apnea Treatment</a>
In November 2024, the Biden-Harris Administration proposed expanding Medicare and Medicaid coverage for anti-obesity medications, aiming to address the high costs that <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/42192091/biden-proposes-medicare-medicaid-access-for-popular-weight-loss-drugs" rel="noreferrer noopener">have drawn criticism</a>.
In its&nbsp;<a target="_blank" href="https://www.cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription-final" rel="noreferrer noopener">fact sheet</a>, the CMS said it &#8220;is not finalizing certain provisions at this time,&#8221; including Part D coverage of anti-obesity medications. &#8220;CMS may address these proposals in future rulemaking, as appropriate,&#8221; according to the fact sheet.
The Biden administration estimated the change could have extended coverage to an additional 3.4 million adults. According to the National Institutes of Health (NIH), approximately 42% of U.S. adults are classified as obese.
As per a media report in March 2024, Medicare may extend coverage for&nbsp;Novo Nordisk&#8217;s weight-loss drug Wegovy (semaglutide) to certain members with a&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/03/37876911/wegovys-success-medicare-contemplates-covering-novo-nordisks-semaglutide-for-heart-health" rel="noreferrer noopener">history of heart disease</a>.&nbsp;
The CMS revealed that Medicare Part D drug-benefit plans, overseen by private insurers, could potentially cover anti-obesity medications under specific circumstances.&nbsp;
In October 2024, the Congressional Budget Office released a <a target="_blank" href="https://www.cbo.gov/system/files/2024-10/60441-medicare-coverage-obesity.pdf" rel="noreferrer noopener">report</a> warning that authorizing anti-obesity treatments for Medicare coverage could increase federal spending by around $35 billion from 2026 to 2034.
The report added that direct federal costs of covering weight loss drugs would increase from $1.6 billion in 2026 to $7.1 billion in 2034.
Relative to the direct costs of the medications, total savings from beneficiaries&#8221; improved health would be small—less than $50 million in 2026 and rising to $1.0 billion in 2034.
In January this year, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on efforts to reduce&nbsp;<a target="_blank" href="https://www.benzinga.com/25/01/43062779/popular-ozempic-wegovy-selected-for-next-round-of-medicare-drug-price-negotiations" rel="noreferrer noopener">prescription drug costs</a>. The list included Novo Nordisk&#8217;s Ozempic, Rybelsus, and Wegovy.
Price Action: At the last check Tuesday, LLY stock was up 3.18% to $746.78, and NVO stock is down 0.41% to $63.38.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44674813/if-tariffs-shift-customer-spending-priorities-these-software-stocks-could-face-slow-growth" target="_blank" rel="noreferrer noopener">If Tariffs Shift Customer Spending Priorities, These Software Stocks Could Face Slow Growth</a></li>
</ul>
Photo by KK Stock via Shutterstock

Biotech

Government

Health Care

General

Trump Administration Reverses Biden's Plan For Medicare Coverage Of Obesity Drugs Like Ozempic And Zepbound

Keybanc analyst Steve Barger maintains Flex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NASDAQ">FLEX</a>) with a Overweight and lowers the price target from $46 to $35.

FLEX

Keybanc Maintains Overweight on Flex, Lowers Price Target to $35

Susquehanna analyst Bascome Majors maintains Greenbrier Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) with a Positive and lowers the price target from $75 to $52.

Susquehanna Maintains Positive on Greenbrier Companies, Lowers Price Target to $52

JP Morgan analyst Richard Shane maintains Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) with a Overweight and lowers the price target from $76 to $50.

JP Morgan Maintains Overweight on Synchrony Financial, Lowers Price Target to $50

Stifel analyst Steven Wieczynski maintains OneSpaWorld Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSW#NASDAQ">OSW</a>) with a Buy and lowers the price target from $25 to $21.

Stifel Maintains Buy on OneSpaWorld Hldgs, Lowers Price Target to $21

LEVI

Levi Strauss shares are trading lower after the company reported worse-than-expected Q1 sales results. Also, Stifel, JP Morgan, and Telsey Advisory Group cut their respective price targets on the stock.

Keybanc analyst Jeffrey Hammond maintains Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) with a Overweight and lowers the price target from $340 to $325.

Keybanc Maintains Overweight on Eaton Corp, Lowers Price Target to $325

Stifel analyst Steven Wieczynski maintains Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) with a Buy and lowers the price target from $310 to $265.

Stifel Maintains Buy on Royal Caribbean Gr, Lowers Price Target to $265

<a href="https://www.finance.senate.gov/hearings/the-presidents-2025-trade-policy-agenda" title="https://www.finance.senate.gov/hearings/the-presidents-2025-trade-policy-agenda">https://www.finance.senate.gov/hearings/the-presidents-2025-trade-policy-agenda</a>

Macro Economic Events

Politics

Global

Economics

U.S. Trade Representative Jamieson Greer Says If Countries Come To Us For Tariff Negotiations They Will Need To Reduce Trade Barriers

JP Morgan analyst Richard Shane maintains Discover Financial servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>) with a Neutral and lowers the price target from $169 to $129.

JP Morgan Maintains Neutral on Discover Financial servs, Lowers Price Target to $129

Investors with a lot of money to spend have taken a bullish stance on Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NET, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Cloudflare.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 25%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $165,144, and 5 are calls, for a total amount of $479,462.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $80.0 and $135.0 for Cloudflare, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Cloudflare's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Cloudflare's whale trades within a strike price range from $80.0 to $135.0 in the last 30 days. 
<h3>Cloudflare Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744124654_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$16.9</td>
<td>$16.7</td>
<td>$16.9</td>
<td>$97.50</td>
<td>$236.6K</td>
<td align="right">249</td>
<td align="right">51</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$11.4</td>
<td>$10.1</td>
<td>$10.68</td>
<td>$94.00</td>
<td>$106.9K</td>
<td align="right">120</td>
<td align="right">100</td>
</tr>
<tr>
<td>NET</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$17.35</td>
<td>$15.75</td>
<td>$15.75</td>
<td>$80.00</td>
<td>$94.5K</td>
<td align="right">112</td>
<td align="right">0</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$17.1</td>
<td>$16.65</td>
<td>$16.78</td>
<td>$97.50</td>
<td>$65.4K</td>
<td align="right">249</td>
<td align="right">41</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$11.95</td>
<td>$11.85</td>
<td>$11.85</td>
<td>$135.00</td>
<td>$40.4K</td>
<td align="right">207</td>
<td align="right">42</td>
</tr>
</tbody>
</table>

<h3>About Cloudflare</h3>
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
After a thorough review of the options trading surrounding Cloudflare, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Cloudflare</h3>
<ul>
<li>With a volume of 1,348,932, the price of NET is up 5.54% at $103.81. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 23 days.</li>
</ul>
<h3>What The Experts Say On Cloudflare</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $147.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from UBS persists with their Neutral rating on Cloudflare, maintaining a target price of $135. 
&#x2A; In a cautious move, an analyst from Citizens Capital Markets downgraded its rating to Market Outperform, setting a price target of $180. 
&#x2A; Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Cloudflare, targeting a price of $148. 
&#x2A; Maintaining their stance, an analyst from Needham continues to hold a Buy rating for Cloudflare, targeting a price of $145. 
&#x2A; An analyst from Piper Sandler persists with their Neutral rating on Cloudflare, maintaining a target price of $131. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cloudflare options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Markets

Smart Money Is Betting Big In NET Options

Investors with a lot of money to spend have taken a bearish stance on JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with JPM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 39 uncommon options trades for JPMorgan Chase.
This isn't normal.
The overall sentiment of these big-money traders is split between 28% bullish and 66%, bearish.
Out of all of the special options we uncovered, 15 are puts, for a total amount of $984,499, and 24 are calls, for a total amount of $1,720,994.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $130.0 to $330.0 for JPMorgan Chase over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in JPMorgan Chase's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to JPMorgan Chase's substantial trades, within a strike price spectrum from $130.0 to $330.0 over the preceding 30 days.
<h3>JPMorgan Chase Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744124649_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$17.85</td>
<td>$17.8</td>
<td>$17.85</td>
<td>$250.00</td>
<td>$508.7K</td>
<td>504</td>
<td align="right">424</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$6.75</td>
<td>$6.55</td>
<td>$6.55</td>
<td>$230.00</td>
<td>$196.5K</td>
<td>1.8K</td>
<td align="right">321</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$19.85</td>
<td>$19.25</td>
<td>$19.51</td>
<td>$235.00</td>
<td>$126.7K</td>
<td>2.2K</td>
<td align="right">196</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$19.5</td>
<td>$19.1</td>
<td>$19.3</td>
<td>$235.00</td>
<td>$107.1K</td>
<td>2.2K</td>
<td align="right">55</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$72.1</td>
<td>$70.5</td>
<td>$70.5</td>
<td>$170.00</td>
<td>$105.7K</td>
<td>127</td>
<td align="right">15</td>
</tr>
</tbody>
</table>

<h3>About JPMorgan Chase</h3>
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4 trillion in assets. It is organized into four major segments: consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
<h3>Present Market Standing of JPMorgan Chase</h3>
<ul>
<li>Trading volume stands at 4,696,848, with JPM's price up by 5.4%, positioned at $226.03.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 3 days.</li>
</ul>
<h3>Expert Opinions on JPMorgan Chase</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $271.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Hold rating for JPMorgan Chase, targeting a price of $264. 
&#x2A; Maintaining their stance, an analyst from Evercore ISI Group continues to hold a Outperform rating for JPMorgan Chase, targeting a price of $265. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for JPMorgan Chase, targeting a price of $284. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for JPMorgan Chase with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Looking At JPMorgan Chase's Recent Unusual Options Activity

Investors with a lot of money to spend have taken a bullish stance on Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AMAT, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 14 uncommon options trades for Applied Mat.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 35%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $846,384, and 8 are calls, for a total amount of $12,281,202.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $128.0 and $150.0 for Applied Mat, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Applied Mat stands at 445.25, with a total volume reaching 18,529.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Applied Mat, situated within the strike price corridor from $128.0 to $150.0, throughout the last 30 days.
<h3>Applied Mat Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744124645_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$35.5</td>
<td>$33.3</td>
<td>$35.9</td>
<td>$135.00</td>
<td>$11.8M</td>
<td>20</td>
<td>3.2K</td>
</tr>
<tr>
<td>AMAT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$19.75</td>
<td>$16.3</td>
<td>$17.0</td>
<td>$140.00</td>
<td>$680.0K</td>
<td>74</td>
<td>400</td>
</tr>
<tr>
<td>AMAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$34.6</td>
<td>$32.95</td>
<td>$34.6</td>
<td>$135.00</td>
<td>$155.7K</td>
<td>20</td>
<td>3.3K</td>
</tr>
<tr>
<td>AMAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$36.4</td>
<td>$34.15</td>
<td>$36.4</td>
<td>$135.00</td>
<td>$109.2K</td>
<td>20</td>
<td>3.3K</td>
</tr>
<tr>
<td>AMAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$19.2</td>
<td>$18.25</td>
<td>$18.45</td>
<td>$130.00</td>
<td>$55.3K</td>
<td>1.3K</td>
<td>666</td>
</tr>
</tbody>
</table>

<h3>About Applied Mat</h3>
Applied Materials Inc is the largest semiconductor wafer fabrication equipment, or WFE, manufacturer in the world. Applied Materials has a broad portfolio spanning nearly every corner of the WFE ecosystem. Specifically, Applied Materials holds a market share leadership position in deposition, which entails the layering of new materials on semiconductor wafers. It is more exposed to general-purpose logic chips made at integrated device manufacturers and foundries. It counts the largest chipmakers in the world as customers, including TSMC, Intel, and Samsung.
In light of the recent options history for Applied Mat, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Applied Mat's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,459,457, with AMAT's price up by 5.45%, positioned at $140.09.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 37 days.</li>
</ul>
<h3>What Analysts Are Saying About Applied Mat</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $195.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Jefferies has elevated its stance to Buy, setting a new price target at $195. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Applied Mat, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Comments

Vantage Towers

Notizie

Ultime notizie per Vantage Towers (OTC:VTAGY) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO